February 24, 2025 – Two of Hawaii’s leading cancer care organizations, the University of Hawaii Cancer Center and The Queen’s Health Systems, are partnering to enhance cancer care in the state.
The two organizations signed a memorandum of understanding to develop oncology clinic space at the UH Cancer Center in Kakaʻako. This collaboration will integrate Queen’s oncology services into the UH Cancer Center’s research facilities, providing comprehensive cancer care and early-phase clinical trials under one roof. It will also mark the first time the UH offers on-campus clinical services for cancer patients.
Queen’s will lease space on the third and fourth floors of the center’s ʻewa wing, offering medical oncology, surgical oncology, and chemotherapy infusion services. Meanwhile, Hoʻōla, Hawaiʻi’s first early-phase clinical research center for cancer, is under construction on the first and second floors and is set to open by year’s end. A collaborative effort with the Hawai‘i Cancer Consortium, Hoʻōla will allow local cancer patients to access cutting-edge treatments without traveling to the mainland.
In September 2024, the UH Cancer Center renewed its National Cancer Institute designation, maintaining its place among the nation’s top 4% of cancer centers. Later this year, it will launch early-phase clinical trial cancer treatments, a first for Hawaii, further strengthening its mission to improve cancer care for the state’s diverse population.
Queen’s Medical Center, recently ranked Hawaii’s top hospital by U.S. News & World Report, also holds accreditation from the American College of Surgeons Commission on Cancer, ensuring patients receive comprehensive care with state-of-the-art services.